Published in Neth Heart J on October 01, 2011
Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit? Neth Heart J (2013) 1.35
Optimisation of cardiac resynchronization therapy in clinical practice during exercise. Neth Heart J (2013) 0.86
Phantom shocks: innocent bystander or complication of implantable cardioverter defibrillator therapy? Neth Heart J (2013) 0.75
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res (2000) 3.68
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J (2001) 3.02
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation (1988) 2.86
Cardiac conduction defects associate with mutations in SCN5A. Nat Genet (1999) 2.73
A sodium-channel mutation causes isolated cardiac conduction disease. Nature (2001) 2.67
Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol (2001) 2.57
Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA (1995) 2.20
Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res (2000) 2.17
Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation. Barcelona Discussion Group. Working Group on Arrhythmias of the European Society of Cardiology. Europace (1999) 2.08
Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol (1990) 2.05
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
Magnetic navigation in AV nodal re-entrant tachycardia study: early results of ablation with one- and three-magnet catheters. Europace (2006) 1.80
Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation (1998) 1.74
LocaLisa: new technique for real-time 3-dimensional localization of regular intracardiac electrodes. Circulation (1999) 1.71
Psychosocial functioning of the adult with congenital heart disease: a 20-33 years follow-up. Eur Heart J (2003) 1.65
Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol (1996) 1.63
Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J (2000) 1.55
Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol (2000) 1.54
COPD and cancer mortality: the influence of statins. Thorax (2009) 1.53
Persistent precordial "hyperacute" T-waves signify proximal left anterior descending artery occlusion. Heart (2009) 1.51
Comparison of late results of surgical or radiofrequency catheter modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. Eur Heart J (1999) 1.46
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet (1999) 1.46
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol (2001) 1.46
Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol (1999) 1.44
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias. Eur Heart J (1997) 1.43
An equine model of chronic atrial fibrillation: methodology. Vet J (2002) 1.42
Changes in conduction velocity during acute ischemia in ventricular myocardium of the isolated porcine heart. Circulation (1986) 1.42
T wave normalization during dobutamine stress testing in patients with non-Q wave myocardial infarction. A marker of myocardial ischaemia? Eur Heart J (1996) 1.42
Cardiac anatomy and diastolic filling in professional road cyclists. Eur J Appl Physiol Occup Physiol (1993) 1.41
Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol (1996) 1.40
Mortality and repeat interventions up until 20 years after aorto-coronary bypass surgery with saphenous vein grafts. A follow-up study of 1041 patients. Eur Heart J (2000) 1.39
Women fare no worse than men 10 years after attempted coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.39
[Aberrant origin of the left coronary artery from the pulmonary artery as cause of ventricular fibrillation in a young woman]. Ned Tijdschr Geneeskd (1993) 1.39
Temporary pacing after His bundle ablation for drug-refractory atrial fibrillation: a risky enterprise? Europace (2000) 1.38
Persisting zones of slow impulse conduction in developing chicken hearts. Circ Res (1992) 1.37
The subendocardial border zone during acute ischemia of the rabbit heart: an electrophysiologic, metabolic, and morphologic correlative study. Circulation (1986) 1.35
Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res (1999) 1.34
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1999) 1.32
Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol (1998) 1.26
Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Circulation (2001) 1.22
CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia. Eur Heart J (2004) 1.21
Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands : An expert consensus report of the Netherlands Society of Cardiology. Neth Heart J (2012) 1.16
Morphology of electrophysiologically identified junctions between Purkinje fibers and ventricular muscle in rabbit and pig hearts. Circ Res (1991) 1.14
ICDs at higher age and clinical risk factors. Neth Heart J (2014) 1.13
Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr (2000) 1.12
Adenosine induced ventricular arrhythmias in the emergency room. Pacing Clin Electrophysiol (2001) 1.11
Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol (1999) 1.10
Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents. J Intern Med (2007) 1.10
Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc Res (2001) 1.10
The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies. Clin Res Cardiol (2006) 1.09
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation (1986) 1.08
Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Neth Heart J (2009) 1.07
OPTImal CArdiac REhabilitation (OPTICARE) following Acute Coronary Syndromes: Rationale and design of a randomised, controlled trial to investigate the benefits of expanded educational and behavioural intervention programs. Neth Heart J (2013) 1.07
Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. J Am Coll Cardiol (2000) 1.06
Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction. Eur Heart J (1999) 1.05
ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. J Toxicol Clin Toxicol (1998) 1.04
Clinical outcome of ablation for long-standing persistent atrial fibrillation with or without defragmentation. Neth Heart J (2014) 1.00
Electrocardiographic and morphometric features in patients with ventricular tachycardia of right ventricular origin. Heart (1998) 1.00
Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol (1995) 1.00
Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart (2003) 1.00
Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation (1997) 0.99
The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg (2007) 0.99
Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Europace (2001) 0.98
Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol (1997) 0.98
Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur J Hum Genet (2007) 0.97
Long-term performance of the St Jude Riata 1580-1582 ICD lead family. Neth Heart J (2013) 0.96
Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations. Ann Thorac Surg (1998) 0.95
Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol (1999) 0.95
First-line evaluation of coronary artery disease with coronary calcium scanning or exercise electrocardiography. Int J Cardiol (2011) 0.95
Evaluation of six minute walking test in patients with single chamber rate responsive pacemakers. Br Heart J (1994) 0.93
Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care (1998) 0.92
Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum Mutat (1999) 0.92
Journal metrics for the Netherlands Heart Journal. Neth Heart J (2011) 0.92
Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J (1997) 0.91
Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart (2001) 0.91
Predicting the long-QT genotype from clinical data: from sense to science. Circulation (2000) 0.90
Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump. Neth Heart J (2011) 0.89
Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med (1998) 0.89
Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters. J Interv Card Electrophysiol (2008) 0.89
Ten year follow-up after radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia in the early days forever cured, or a source for new arrhythmias? Pacing Clin Electrophysiol (2005) 0.88
Molecular mechanisms of arrhythmias. Rev Port Cardiol (1998) 0.88
Long-term (subacute) potassium treatment in congenital HERG-related long QT syndrome (LQTS2). J Cardiovasc Electrophysiol (1999) 0.87
Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction. J Nucl Cardiol (2001) 0.87
Use of remote monitoring in the management of system-related complications in implantable defibrillator patients. Neth Heart J (2012) 0.87
Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group. Am J Cardiol (1995) 0.87
Anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg (1993) 0.86
Measurements and day-to-day variabilities of left ventricular volumes and ejection fraction by three-dimensional echocardiography and comparison with magnetic resonance imaging. Am J Cardiol (1998) 0.86
Significance of resting wall motion abnormalities in 2-dimensional echocardiography in patients without previous myocardial infarction referred for pharmacologic stress testing. J Am Soc Echocardiogr (2000) 0.86
Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. Am J Cardiol (1996) 0.86
The combined effects of hypoxia, high K+, and acidosis on the intracellular sodium activity and resting potential in guinea pig papillary muscle. Circ Res (1986) 0.85
The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene. Hum Genet (1997) 0.85
Genomic organisation and chromosomal localisation of two members of the KCND ion channel family, KCND2 and KCND3. Hum Genet (2000) 0.85